Classification
- Anatomical main groupLAntineoplastic and immunomodulating agents
- Therapeutic subgroupL01Antineoplastic agents
- Pharmacological subgroupL01E
- Chemical subgroupL01EL
- Chemical substanceL01EL01Ibrutinib
Where it is registered
Each register with its number of medicines and a few of them.
Canada
Health Canada · 6 medicines
- Imbruvica70 MG / ML · Suspension · Janssen INC
- Imbruvica140 MG · Capsule · Janssen INC
- Imbruvica140 MG · Tablet · Janssen INC
- Imbruvica420 MG · Tablet · Janssen INC
Spain
AEMPS · 6 medicines



